Entropy Technologies’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-124,068
Closed -$2.39M 1191
2026
Q1
$2.39M Buy
124,068
+93,021
+300% +$1.83M 0.11% 250
2025
Q4
$588K Sell
31,047
-1,796
-5% -$33.3K 0.03% 517
2025
Q3
$612K Buy
32,843
+12,243
+59% +$229K 0.05% 467
2025
Q2
$380K Sell
20,600
-5,340
-21% -$94.8K 0.03% 552
2025
Q1
$453K Buy
+25,940
New +$437K 0.04% 454
2024
Q4
Sell
-13,922
Closed -$259K 960
2024
Q3
$259K Buy
+13,922
New +$235K 0.03% 580

Other funds holding SBRA

Entropy Technologies's SBRA Position: Q2 2026 in Review

Entropy Technologies sold out of Sabra Healthcare REIT (SBRA) in Q2 2026, closing a stake of 124,068 shares — an estimated $2.39M sold.

Entropy Technologies first reported a position in SBRA in Q3 2024 and held it in 6 quarters. The position peaked at $2.39M in Q1 2026. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Entropy Technologies reported no remaining Sabra Healthcare REIT position as of Q2 2026 after selling out during the quarter.
  • Entropy Technologies sold 124,068 Sabra Healthcare REIT shares in Q2 2026, an estimated $2.39M.
  • Entropy Technologies first reported a position in Sabra Healthcare REIT in Q3 2024 and held it in 6 quarters.
  • Entropy Technologies's Sabra Healthcare REIT position peaked at $2.39M in Q1 2026.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.